What you should know:
1. Mr. Fusco will join ONS as chief growth officer. He brings 12 years of experience to the orthopedic and neurosurgery practice.
2. He will lead ONS’ growth efforts. ONS co-founders and executive committee members Seth Miller, MD, and Mark Camel, MD, said in a joint statement, “Chris’ extensive expertise and track record of developing long term partnerships with physicians will enhance our ability to serve more patients with the highest quality of care.”
3. ONS is backed by private equity firm Kohlberg & Co., which invested in the practice in July 2019.
More articles on orthopedics:
3 spine, orthopedic device company acquisitions — September
Drs. Eric Smith, David Helfet & more: 6 orthopedic surgeons making the news
3 spine, neurosurgeons surgeons receiving honors — September
